Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
4
×
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
boston top stories
cancer immunotherapy
clinical trials
covid-19
deals
diagnostics
europe blog main
europe top stories
fda
forty seven
gilead sciences
What
sciences
4
×
acquisitions
bio
ceo
daniel
gilead
ipo
latest
life
million
new
o’day
plans
roundup
science
week
announced
biggest
biotechs
build
buy
cash
club
collabs
committed
companies
company’s
continued
covid
crop
deal
debut
deploy
drug
dyne’s
exceeded
far
firms
fund
gilead’s
Language
unset
Current search:
sciences
×
biotech
×
" raleigh-durham top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M